Posted: 27 July 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) recommended the ATH434-201…
Posted: 27 July 2023 The Burnet Diagnostics Initiative (BDI) has reached a major milestone, having recently been awarded ISO 9001 certification. It is a significant step forward for the BDI, which has a strong focus on translational research, including developing…
Posted: 27 July 2023 Australia’s only biomedical manufacturing site where CAR T-cells and other “living” cancer therapies can be made at commercial scale has expanded to meet future patient demand. Federal Minister for Health and Aged Care, the…
Posted: 27 July 2023 Cell Therapies Pty Ltd. is excited to announce the opening of new cell and gene therapy GMP manufacturing facilities to meet future patient demand at the Peter MacCallum Cancer Centre. As Australia’s only biomedical…
Posted: 27 July 2023 Partnership will see co-investment and collaboration to advance promising biomedical research. BioCurate, an independently operated joint venture between the University of Melbourne and Monash University, announced today it has signed a Memorandum of Understanding…
Posted: 27 July 2023 Monash University-led research into growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning, has been awarded almost $600,000 AUD in the prestigious National Intelligence and Security Discovery…
Posted: 27 July 2023 Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion. Published recently in Nature Machine Intelligence, the research addressed the…
Posted: 26 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it has entered a new partnership with The University of Queensland’s (UQ’s) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub), which has been awarded $4.8 million from…
Posted: 26 July 2023 Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has enrolled its first cohort of 30 participants into the Travelan® clinical trial to evaluate its efficacy to prevent infectious diarrhea caused by enterotoxigenic Escherichia coli (ETEC). Travelan® is known to…
Posted: 26 July 2023 Are you part of the specialist digital health workforce? Are you responsible for health data, information, knowledge, or technology? Be part of the census that captures the vital information about this workforce. This information…
Posted: 25 July 2023 MTPConnect and the Minister for Health and Aged Care, Hon. Mark Butler MP, today announced $6.2 million of funding for six medical technology projects through the Clinical Translation and Commercialisation Medtech (CTCM) Program. The CTCM program, a Medical…
Posted: 25 July 2023 Digital health company Cardihab has recently announced a partnership with Roche Diagnostics Australia Pty Ltd that is focused on improving quality and standards of care, that deliver better outcomes for people living with cardiovascular conditions in Australia.…